Skip to main content

JANE STREET GROUP, LLC

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in PLRX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$449,559
-$348,044 QoQ
Shares Held
356,794
-45.4% QoQ
Ownership
0.576%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PLRX Over Time

Shares Held

Position Value (USD)

Derivatives in PLRX

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$15,750
PutShares
12,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. PLRX ranks #167 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PLRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,750 12,500
2026-03-31 $449,559 356,794
2025-12-31 $797,603 653,774
2025-09-30 $562,883 380,327
2025-06-30 $375,156 323,412
2025-03-31 $184,566 136,716
2024-12-31 $2,397,136 182,015
2024-12-31 $2,551,029 193,700
2024-09-30 $2,063,761 184,100
2024-09-30 $2,093,197 186,726
2024-06-30 $2,553,103 237,498
2024-03-31 $1,920,787 128,912
2023-12-31 $1,614,397 89,144
2023-09-30 $402,963 23,239
2023-06-30 $1,421,114 78,428
2023-03-31 $5,919,297 222,530
2022-12-31 $856,181 44,293
2020-06-30 $434,606 13,389